These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 7530605

  • 1. TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion.
    Miller RT, Cattley RC, Marsman DS, Lyght O, Popp JA.
    Carcinogenesis; 1995 Jan; 16(1):77-82. PubMed ID: 7530605
    [Abstract] [Full Text] [Related]

  • 2. Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643.
    Marsman DS, Popp JA.
    Carcinogenesis; 1994 Jan; 15(1):111-7. PubMed ID: 7507413
    [Abstract] [Full Text] [Related]

  • 3. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
    Cattley RC, Popp JA.
    Cancer Res; 1989 Jun 15; 49(12):3246-51. PubMed ID: 2566380
    [Abstract] [Full Text] [Related]

  • 4. Effect on the expression of c-met, c-myc and PPAR-alpha in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643.
    Miller RT, Glover SE, Stewart WS, Corton JC, Popp JA, Cattley RC.
    Carcinogenesis; 1996 Jun 15; 17(6):1337-41. PubMed ID: 8681452
    [Abstract] [Full Text] [Related]

  • 5. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
    Tamano S, Merlino GT, Ward JM.
    Carcinogenesis; 1994 Sep 15; 15(9):1791-8. PubMed ID: 7923571
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci.
    Steinmetz KL, Klaunig JE.
    Toxicol Appl Pharmacol; 1996 Sep 15; 140(1):131-45. PubMed ID: 8806879
    [Abstract] [Full Text] [Related]

  • 7. Initiator-specific promotion of hepatocarcinogenesis by WY-14,643 and clofibrate.
    Cattley RC, Kato M, Popp JA, Teets VJ, Voss KS.
    Carcinogenesis; 1994 Aug 15; 15(8):1763-6. PubMed ID: 8055661
    [Abstract] [Full Text] [Related]

  • 8. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver.
    Moser GJ, Wolf DC, Goldsworthy TL.
    Toxicol Pathol; 1997 Aug 15; 25(3):275-83. PubMed ID: 9210259
    [Abstract] [Full Text] [Related]

  • 9. Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver.
    Cattley RC, Marsman DS, Popp JA.
    Carcinogenesis; 1991 Mar 15; 12(3):469-73. PubMed ID: 1849052
    [Abstract] [Full Text] [Related]

  • 10. Enhancement by Wy-14,643, a hepatic peroxisome proliferator, of diethylnitrosamine-initiated hepatic tumorigenesis in the rat.
    Reddy JK, Rao MS.
    Br J Cancer; 1978 Oct 15; 38(4):537-43. PubMed ID: 728341
    [Abstract] [Full Text] [Related]

  • 11. Lack of comitogenicity by the peroxisome proliferator hepatocarcinogens, Wy-14,643 and clofibric acid.
    Marsman DS, Swanson-Pfeiffer CL, Popp JA.
    Toxicol Appl Pharmacol; 1993 Sep 15; 122(1):1-6. PubMed ID: 8378924
    [Abstract] [Full Text] [Related]

  • 12. Presence of a threshold for promoting effects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat.
    Kitano M, Ichihara T, Matsuda T, Wanibuchi H, Tamano S, Hagiwara A, Imaoka S, Funae Y, Shirai T, Fukushima S.
    Carcinogenesis; 1998 Aug 15; 19(8):1475-80. PubMed ID: 9744545
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis, mitosis and cyclophilin-40 expression in regressing peroxisome proliferator-induced adenomas.
    Miller RT, Anderson SP, Corton JC, Cattley RC.
    Carcinogenesis; 2000 Apr 15; 21(4):647-52. PubMed ID: 10753199
    [Abstract] [Full Text] [Related]

  • 14. Cell proliferation and regulation of negative growth factors in mouse liver foci.
    Moser GJ, Wolf DC, Harden R, Standeven AM, Mills J, Jirtle RL, Goldsworthy TL.
    Carcinogenesis; 1996 Sep 15; 17(9):1835-40. PubMed ID: 8824503
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643.
    Glauert HP, Eyigor A, Tharappel JC, Cooper S, Lee EY, Spear BT.
    Toxicol Sci; 2006 Apr 15; 90(2):331-6. PubMed ID: 16434500
    [Abstract] [Full Text] [Related]

  • 16. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
    Marsman DS, Cattley RC, Conway JG, Popp JA.
    Cancer Res; 1988 Dec 01; 48(23):6739-44. PubMed ID: 3180084
    [Abstract] [Full Text] [Related]

  • 17. Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine.
    Williams GM, Gebhardt R, Sirma H, Stenbäck F.
    Carcinogenesis; 1993 Oct 01; 14(10):2149-56. PubMed ID: 8106178
    [Abstract] [Full Text] [Related]

  • 18. An acyclic retinoid, NIK-333, inhibits N-diethylnitrosamine-induced rat hepatocarcinogenesis through suppression of TGF-alpha expression and cell proliferation.
    Kagawa M, Sano T, Ishibashi N, Hashimoto M, Okuno M, Moriwaki H, Suzuki R, Kohno H, Tanaka T.
    Carcinogenesis; 2004 Jun 01; 25(6):979-85. PubMed ID: 14742314
    [Abstract] [Full Text] [Related]

  • 19. Cyclosporine stimulates hepatocyte proliferation and accelerates development of hepatocellular carcinomas in rats.
    Masuhara M, Ogasawara H, Katyal SL, Nakamura T, Shinozuka H.
    Carcinogenesis; 1993 Aug 01; 14(8):1579-84. PubMed ID: 8353842
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.